NCT00977717|Completed
Loading search results
Sponsor study identifier
observational
100
1 country
1
Study Start
September 2008
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
January 2010
Actual (reported)Study Completion
April 2010
Actual (reported)In order to explore genetic factors that may determine the neurotoxicity of oxaliplatin-based chemotherapy, germinal gene polymorphisms will be analyzed.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
April 2010
Actual (reported)Click on a node to explore related trials.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
September 2008
Date type not reportedThis date has not been verified as actual or estimated.
September 3, 2009
Actual (reported)September 16, 2009
Actual (reported)January 2010
Actual (reported)April 2010
Actual (reported)neuropathy
six months
Stage III colorectal cancer patients who are treated with adjuvant FOLFOX chemotherapy
Curatively resected stage III colon cancer
Samsung Medical Center
Seoul, 135 710, South Korea
Baek KK, Lee J, Park SH, Park JO, Park YS, Lim HY, Kang WK, Cho YB, Yun SH, Kim HC, Lee WY, Chun HK. Oxaliplatin-induced chronic peripheral neurotoxicity: a prospective analysis in patients with colorectal cancer. Cancer Res Treat. 2010 Dec;42(4):185-90. doi: 10.4143/crt.2010.42.4.185. Epub 2010 Dec 31.
DNA will be extracted from peripheral blood samples using DNA isolation kit.
Se Hoon Park, MD
Samsung Medical Center, Seoul, Korea
First Submitted
September 3, 2009
First Posted
September 16, 2009
Study Start
September 2008
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
January 2010
Actual (reported)Contact the study team to confirm eligibility.
Study Completion
April 2010
Actual (reported)Last Updated
April 19, 2010
Record last verified: 2010-04
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: